Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

The intestine as a regulator of cholesterol homeostasis in diabetes.

Tomkin GH.

Atheroscler Suppl. 2008 Sep;9(2):27-32. doi: 10.1016/j.atherosclerosissup.2008.05.012. Epub 2008 Aug 6. Review.

PMID:
18693145
2.

Dyslipidaemia--hepatic and intestinal cross-talk.

Tomkin GH.

Atheroscler Suppl. 2010 Jun;11(1):5-9. doi: 10.1016/j.atherosclerosissup.2010.03.005. Review.

PMID:
20434963
3.

Dyslipidaemia of diabetes and the intestine.

Tomkin GH, Owens D.

World J Diabetes. 2015 Jul 10;6(7):970-7. doi: 10.4239/wjd.v6.i7.970. Review.

4.

Model of intestinal chylomicron over-production and ezetimibe treatment: impact on the retention of cholesterol in arterial vessels.

Mangat R, Warnakula S, Wang Y, Russell JC, Uwiera R, Vine DF, Proctor SD.

Atheroscler Suppl. 2010 Jun;11(1):17-24. doi: 10.1016/j.atherosclerosissup.2010.04.043. Epub 2010 May 14. Review.

PMID:
20471328
5.

Targets for intervention in dyslipidemia in diabetes.

Tomkin GH.

Diabetes Care. 2008 Feb;31 Suppl 2:S241-8. doi: 10.2337/dc08-s260. Review.

PMID:
18227492
6.

Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome.

Arca M.

Atheroscler Suppl. 2015 Feb;17:12-6. doi: 10.1016/S1567-5688(15)50004-4. Review.

PMID:
25659871
7.

ABCG5/ABCG8 in cholesterol excretion and atherosclerosis.

Yu XH, Qian K, Jiang N, Zheng XL, Cayabyab FS, Tang CK.

Clin Chim Acta. 2014 Jan 20;428:82-8. doi: 10.1016/j.cca.2013.11.010. Epub 2013 Nov 16. Review.

PMID:
24252657
8.

Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).

Davis HR Jr, Basso F, Hoos LM, Tetzloff G, Lally SM, Altmann SW.

Atheroscler Suppl. 2008 Sep;9(2):77-81. doi: 10.1016/j.atherosclerosissup.2008.05.008. Epub 2008 Jun 27. Review.

PMID:
18585981
9.

New and emerging regulators of intestinal lipoprotein secretion.

Xiao C, Dash S, Morgantini C, Lewis GF.

Atherosclerosis. 2014 Apr;233(2):608-15. doi: 10.1016/j.atherosclerosis.2013.12.047. Epub 2014 Jan 21. Review.

PMID:
24534456
10.

Atherosclerosis, diabetes and lipoproteins.

Tomkin GH.

Expert Rev Cardiovasc Ther. 2010 Jul;8(7):1015-29. doi: 10.1586/erc.10.45. Review.

PMID:
20602562
11.

Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.

Huff MW.

Can J Clin Pharmacol. 2003 Winter;10 Suppl A:26A-32A. Review.

PMID:
14571303
12.

Diabetic dyslipidemia.

Kreisberg RA.

Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.

PMID:
9915665
13.

The extended postprandial phase in diabetes.

Owens D.

Biochem Soc Trans. 2003 Oct;31(Pt 5):1085-9. Review.

PMID:
14505485
14.

New Insights into the Regulation of Chylomicron Production.

Dash S, Xiao C, Morgantini C, Lewis GF.

Annu Rev Nutr. 2015;35:265-94. doi: 10.1146/annurev-nutr-071714-034338. Epub 2015 May 13. Review.

PMID:
25974693
16.

Lipid absorption and intestinal lipoprotein formation.

Green PH, Riley JW.

Aust N Z J Med. 1981 Feb;11(1):84-90. Review.

PMID:
7018485
17.

New insights into how the intestine can regulate lipid homeostasis and impact vascular disease: frontiers for new pharmaceutical therapies to lower cardiovascular disease risk.

Warnakula S, Hsieh J, Adeli K, Hussain MM, Tso P, Proctor SD.

Can J Cardiol. 2011 Mar-Apr;27(2):183-91. doi: 10.1016/j.cjca.2010.12.020. Review.

PMID:
21459267
18.

The ABC of hepatic and intestinal cholesterol transport.

Plösch T, Kosters A, Groen AK, Kuipers F.

Handb Exp Pharmacol. 2005;(170):465-82. Review.

PMID:
16596811
19.

Signposts in the assembly of chylomicrons.

Hussain MM, Kedees MH, Singh K, Athar H, Jamali NZ.

Front Biosci. 2001 Mar 1;6:D320-31. Review.

PMID:
11229873
20.

Formation and transport of chylomicrons by enterocytes to the lymphatics.

Tso P, Balint JA.

Am J Physiol. 1986 Jun;250(6 Pt 1):G715-26. Review.

PMID:
3521320
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk